Clinical Trial Update: Ketotifen Ophthalmic Solution With Emedastine in Patients With Seasonal Allergic Conjunctivitis [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating a combination of ketotifen ophthalmic solution and emedastine for seasonal allergic conjunctivitis has completed, sponsor Novartis re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seasonal Allergic Conjunctivitis

Drugs mentioned

• Emedastine Ophthalmic Solution (emedastine)
• Ketotifen Ophthalmic Solution (ketotifen)

Snippet

Sponsor: Novartis | Conditions: Seasonal Allergic Conjunctivitis | Phase 4 | Status: COMPLETED